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Among the three phases of mRNA translation—initiation, elongation, and termination—initiation
has traditionally been considered to be rate limiting and thus the focus of regulation. Emerging ev-
idence, however, demonstrates that control of ribosome translocation (polypeptide elongation) can
also be regulatory and indeed exerts a profound influence on development, neurologic disease, and
cell stress. The correspondence of mRNA codon usage and the relative abundance of their cognate
tRNAs is equally important for mediating the rate of polypeptide elongation. Here, we discuss
recent results showing that ribosome pausing is a widely used mechanism for controlling transla-
tion and, as a result, biological transitions in health and disease.Introduction
Since translational control became a distinct field of study, the
term ‘‘control’’ for many investigators was synonymous with initi-
ation, the first and most complicated phase of protein synthesis.
Initiation includes formation of the 43S pre-initiation complex, its
association with the mRNA 50 terminal 7mG cap in coordination
with the eIF4F (eIF4A, eIF4G, and eIF4E) complex, scanning of
the 40S ribosomal subunit to the initiation AUG codon, and
joining of the 60S subunit to form the 80S monosome (Hinne-
busch 2014).
Cells generally contain a dearth of the cap-binding factor eIF4E
(Mamane et al., 2004), and its interactionwith eIF4Gandhence its
ability to recruit the translational apparatus is widely regulated by
different classes of protein factors, including the eIF4E binding
proteins (4EBPs) (Richter and Sonenberg, 2005). Additionally,
scanning of the 40S ribosomal subunit along the mRNA can be
impeded by interacting proteins or secondary structure in the
50UTR. Given these distinct control points, tradition has dictated
that initiation would be rate limiting for protein synthesis. More-
over, it makes intuitive sense that the first step in translation
would be the most likely to be regulated. However, emerging ev-
idence indicates that polypeptide elongation (ribosome transit)
can also be regulatory and indeed may be critical for controlling
early development, neural function, and cancer etiology. Here,
we review salient observations pointing to an important role for
regulated ribosome translocation in diverse biological contexts.
Translational Elongation at a Glance
Translational initiation involves dozens of individual polypep-
tides, and given its complexity, it is not surprising that distinct
sub-steps can be regulated. In comparison, translational elonga-
tion is relatively simple. In concert with elongation factor EF-1/
EF-TU and guanosine triphosphate (GTP), an aminoacylated
tRNA enters the A site of the ribosome; cognate tRNA-mRNA
codon recognition then stimulates GTP hydrolysis and eviction
of EF-1/EF-TU from the A site. Concomitantly, the ribosome un-292 Cell 163, October 8, 2015 ª2015 Elsevier Inc.dergoes a conformational shift, stimulating contact between the
30 ends of the aminoacylated tRNA in the A site and the tRNA
bearing the polypeptide chain in the P site. When the two tRNAs
shift position (A to P and P to E site), peptide bond formation oc-
curs as the polypeptide is now transferred to the aminoacylated
tRNA, extending the protein by one amino acid. A second elon-
gation factor, EF-2/EF-G, then enters the A site, hydrolyzing GTP
and resetting the ribosome to a conformation competent to
receive the next aminoacylated tRNA in the A site. The process
repeats itself over and over again (Figure 1).
Despite the ‘‘simplicity’’ of elongation, regulation can and does
occur. Indeed, for decades, we have known that ribosomes stall
after reading only the first 5–30 codons of mRNAs encoding
secreted proteins (Siegel and Walter 1988; Halic et al., 2004).
This activity requires the signal recognition particle (SRP), which
binds the N terminus of the nascent polypeptide and simulta-
neously inserts itself into the ribosome A site (Halic et al.,
2004). Docking of SRP in the ribosomal A site blocks further
tRNA entry, arresting elongation until the ribosome/mRNA com-
plex is localized to the endoplasmic reticulum. The lesson from
SRP function is that A-site occlusion is a viable and potent
means to arrest translational elongation. Thus, any factor (pro-
tein or RNA) that can interact in or near the A site has the potential
to stall elongation by blocking tRNA entry.
In this regard, there are many known factors that do interact
with the A site—all for distinct reasons. The release factors,
eRF1 and eRF3, the elongation factor EF-G, the ribosome recy-
cling factors/mRNA decay factors DOM34 and HBS1, and the
mRNA decay factor SKI7 are all thought to interact at the A
site. Thus, the A site is a busy place and a potential target for
mRNA-specific regulation. A-site occlusion could easily be
achieved by a message-specific regulator provided it has
sequence-specific binding properties for its mRNA transcript
and a motif capable of A-site docking.
The SRP example demonstrates, in clear molecular terms,
how elongation can be regulated. Importantly, the literature
Figure 1. Translational Elongation at a
Glance
Shown are the four basic steps of translational
elongation. The ribosome has three major tRNA
pockets, the A, P, and E sites. The first step of
polypeptide elongation is the recognition and ac-
commodation of the cognate tRNA, as directed by
a mRNA codon, within the ribosomal A site (i). The
cognate tRNA is brought into the ribosome as a
complex with elongation factor 1 (EF-TU in bac-
teria) and GTP. Recognition of the cognate tRNA
catalyzes the hydrolysis of GTP and the eviction of
EF1 from the A site (ii). At this point, the deacylated
tRNA in the E site is also thought to be evicted. The
A-site tRNA and the P-site tRNA move into close
proximity for the peptidyl transfer reaction, where
the growing polypeptide chain is added to the
amino acid on the A-site tRNA (iii). Elongation
factor 2 (EF-G in bacteria) then enters the A site
and completes ribosome translocation by moving
the A-site tRNA to the P site and the P-site de-
acylated tRNA into the E site (iv). The process then
repeats itself over and over again.contains a number of less clear but still tantalizing glimpses of
where modulating ribosome translocation might be a driving
force in regulation. In several of these cases, regulated elonga-
tion is inferred from observations that repressed mRNA co-sed-
iments with polysomes in sucrose gradients and/or that this co-
sedimentation is resistant to puromycin treatment, which causes
release of translating ribosomes. Nevertheless, accumulating
evidence hints to a broad influence of translational elongation
on the control of gene expression.
Control of Elongation during Early Development
Mechanisms of translational control during the early develop-
ment of model organisms are often recapitulated in adult
mammalian tissues. Consider, for example, the case of masked
(i.e., repressed) mRNA in the oocytes (eggs) of sea urchins and
frogs. As the oocytes prepare for fertilization during early
embryogenesis, this mRNA is massively mobilized onto poly-
somes, which coincides with a substantial decrease in ribosome
translocation time (Brandis and Raff 1978; Richter et al., 1982).
These and other observations of this era now seem archaic
because, for themost part, they pre-dated one’s ability to assess
the time required for a ribosome to transit any particular mRNA.
Even so, they illustrate the point that polypeptide elongation
rates can be regulated by cellular transitions.
Masked mRNA is also a hallmark of Drosophila development.
Here, the translation of nanos mRNA, which encodes a poste-
rior pole determinant, is regulated both spatially and temporally.
Although nanosmRNA translation is controlled in multiple ways,Cell 163one is by ribosome stalling (Clark et al.,
2000; Andrews et al., 2011). Nanos
mRNA co-sediments with polyribosomes
in sucrose gradients even though no
Nanos protein is detected; yet, when
the polysomes were added to an in vitro
ribosome run-off system, the stalled poly-
somes resumed their transit and pro-
duced Nanos protein, showing that theywere paused rather than immobilized in an inactive form. This
scenario is somewhat similar to that observed with oskar
mRNA, another posterior pole determinant in Drosophila. Oskar
mRNA also co-sediments with polysomes even though little Os-
kar protein is detected (Braat et al., 2004). Moreover, when
added to an in vitro translation system derived from ovaries, pu-
romycin, an antibiotic that acts on translating ribosomes by
mimicking tRNA and causing premature polypeptide release
and ribosome dissociation, caused only a partial shift of the sedi-
mentation of oskar mRNA to lighter fractions of sucrose gradi-
ents, suggesting that it is associated with stalled ribosomes.
Micro RNAs, which have profoundly changed our notion of
how biological processes are regulated, were discovered during
examination of C. elegans larval development (Lee et al., 1993;
Wightman et al., 1993). In spite of the huge number of studies
that have analyzed miRNA activity, the mechanism(s) by which
they silence mRNA expression remains somewhat enigmatic,
perhaps because they repress translation a number of different
ways. That mRNAs silenced by miRNAs are often eventually de-
stroyed is beyond doubt, but the step(s) at which the silencing
occurs is seemingly manifold. Olsen and Ambros (1999) noted
that although C. elegans lin-4 miRNA inhibited Lin-14 mRNA
translation, the message appeared to be stable and co-sedi-
mented with polysomes in sucrose gradients. This observation
gave rise to the hypothesis that miRNAs repress translation by
stalling ribosomes. Using cell lines, several labs subsequently
found miRNA-inhibited mRNAs that also co-sedimented with
polysomes (Nottrott et al., 2006; Maroney et al., 2006), and one, October 8, 2015 ª2015 Elsevier Inc. 293
proposed that miRNAs promote pre-mature drop-off of trans-
lating ribosomes (Petersen et al., 2006). Although ribosome pro-
files derived from developing zebrafish embryos showed that at
least miR-430 did not induce ribosome drop off (Bazzini et al.,
2012), it remains an open question as to the extent to which
miRNAs can promote post-initiation mRNA silencing.
Synaptic Plasticity in Neurons
Neuronal processes, particularly dendrites, have long been
known to harbor mRNAs whose translation is critical for synaptic
plasticity, the underlying cellular basis of learning and memory
(Kang and Schuman 1996; Martin et al., 1997). The regulation
of dendritic mRNA translation must be considered in conjunction
with cellular localization as mRNAs are transported from cell
bodies into dendrites on molecular motors in a mostly silent
form. The mRNAs are then activated in response to synaptic ac-
tivity (Kanai et al., 2004). Early work found that a substantial
portion of neuronal mRNAs reside in granules that sediment in
sucrose gradients to fractions much heavier than polysomes.
Electron microscopy revealed these granules to be composed
of densely packed polysomes, but because they lack the initia-
tion factors eIF4E and eIF4G, they were thought to represent
stalled ribosomes. Membrane depolarization of neurons by
KCl-stimulated translation partially dispersed the aggregates,
suggesting that the stalled polysomes resumed translation (Kri-
chevsky and Kosik 2001).
In a contemporaneous study, Scheetz et al. (2000) stimulated
synaptoneurosomes (a biochemical preparation of pre- and
post-synaptic compartments) isolated from rat brain with the
neurotransmitter N-methyl-D-aspartate (NMDA) and observed
an increase in eEF2 phosphorylation, which would inactivate
the enzyme and thus slow ribosome translocation. These inves-
tigators found a concurrent increase in the synthesis of the
critical synaptic protein alpha calcium/calmodulin protein kinase
II (aCaMKII) and hypothesized that inhibition of elongation of
somemRNAs allows for the elevated translation of other mRNAs
by mechanisms involving enhanced initiation. This hypothesis
suggests that phospho-eEF2 could discriminate amongmRNAs,
which might be accomplished by, for example, spatial segrega-
tion of some components of the translational apparatus.
A link between eEF2 phosphorylation and synaptic activity
was also observed by Sutton et al. (2007), who found that
eEF2’s enzymatic activity can be toggled by the type of neuro-
transmission to which a neuron is subjected. eEF2 is mostly non-
phosphorylated when neurotransmission is evoked by action
potentials. On the other hand, miniature synaptic transmission,
which is spontaneous in nature and independent of action poten-
tials, results in eEF2 phosphorylation. As might be expected,
protein synthesis is up or downregulated depending on the state
of eEF2 phosphorylation. For this reason, Sutton et al. (2007)
proposed that eEF2 is a sensor that links synaptic activity to local
(i.e., dendritic) control of polypeptide elongation.
More contemporary studies are consistent with these findings.
Using an indirect in vivo ribosome run-off assay in neurons,
Graber et al. (2013) found that mRNAs in dendrites are associ-
ated with stalled polysomes that can be reactivated by stimula-
tion of metabotropic glutamate receptors, which induces long-
term depression (LTD), a protein synthesis-dependent form of294 Cell 163, October 8, 2015 ª2015 Elsevier Inc.synaptic plasticity. Buxbaum et al. (2014) used three-color fluo-
rescence in situ hybridization (FISH) and single-molecule detec-
tion technology to explore actin mRNA masking/unmasking
dynamics in neuronal dendrites. Their results buttress the inter-
pretation that quiescent mRNAs in neurons associate with
stalled ribosomes and that induction of long-term potentiation
(LTP), another form of synaptic plasticity, activates the stalled
ribosomes to complete translation.
Ribosome Stalling in Fragile X Syndrome
Fragile X syndrome is the most common form of inherited intel-
lectual disability and most frequent monogenic cause of autism.
The syndrome is caused by a CGG repeat expansion in the
Fmr1 gene, which causes its transcriptional inactivation. Fmr1
encodes FMRP, an RNA binding protein that represses transla-
tion. In the absence of FMRP, protein synthesis in the brain
is excessive, and it is commonly thought that this leads to syn-
aptic dysfunction and other anomalies associated with this
disease.
Several studies have shown that FMRP co-sediments with
polysomes, suggesting that it inhibits translation by stalling ribo-
somes (Feng et al., 1997; Corbin et al., 1997; Stefani et al., 2004).
In a groundbreaking study by Darnell et al. (2011), FMRP was
found to crosslink to nearly 1,000 mRNAs in the brain in an
experiment where UV irradiation to covalently link RNAs and pro-
teins is followed by immunoprecipitation and deep sequencing
(this procedure is referred to as ‘‘CLIP’’). Surprisingly, most of
the sites in mRNA to which FMRP was crosslinked were distrib-
uted in coding regions in a cis element-independent manner.
Moreover, extensive analysis of the associated mRNAs showed
them to co-sediment with polysomes but to be largely resistant
to puromycin treatment (because puromycin causes dissocia-
tion of transiting, but not static ribosomes, one infers that ribo-
somes do not move, or move only very slowing, on FMRP-bound
mRNAs). By contrast, mRNAs not crosslinked to FMRP dissoci-
ated from polysomes following puromycin treatment and sedi-
mented with the nontranslating ribonucleoprotein (RNP) frac-
tions of sucrose gradients. Therefore, a synthesis of these two
observations—that FMRP binds to coding regions and that the
ribosomes on such mRNAs do not transit—strongly implies
that FMRP stalls ribosomes.
In a number of cases, mouse models have shown that the
excessive protein synthesis in the Fragile X brain can be restored
to normal levels if a second gene is deleted, which leads rescue
of many disease phenotypes (Do¨len et al., 2007; Bhattacharya
et al., 2012; Udagawa et al., 2013; Gross et al., 2015). For
example, Udagawa et al. (2013) focused on CPEB1, which
generally (although not necessarily exclusively) stimulates trans-
lation in the brain and co-localizes and co-immunoprecipitates
with FMRP. The binding site for CPEB1 is present in about
30% of the FMRP-associated mRNAs and thus has the potential
to regulate their expression. These authors proposed that trans-
lational homeostasis in the brain might be restored if the CPEB1
gene, as well as Fmr1, was disrupted. Indeed, not only was the
excessive protein synthesis restored to normal levels in FMRP/
CPEB double-knockout mice, but so too were a variety of path-
ophysiologies associated with Fragile X. Moreover, Udagawa
et al. (2013) found that ribosome transit time in the Fragile X brain
Figure 2. Three Examples of Regulated
Polypeptide Elongation
FMRP is proposed to bind both the ribosome and
the engaged mRNA to impede ribosome trans-
location. FMRP is not produced when the Fmr1
gene is inactivated, which results in an elevated
rate of polypeptide elongation and the Fragile X
syndrome (top). In the brain, a mutated tissue-
specific tRNA causes ribosome stalling at its cor-
responding codon. Neurodegeneration occurs if
GTPBP2 is also mutated (middle). During proteo-
toxic stress, the chaperone HSC70, which nor-
mally binds the nascent peptide as it emerges
from the ribosome, is titrated by misfolded pro-
teins and causes ribosome stalling after reading
about 50 codons (bottom).was45% faster than in the wild-type brain, which was rescued
to normal in the FMRP/CPEB1 double-knockout brain. How
the loss of CPEB1 slows ribosome translocation in the FMRP-
deficient brain is unknown, but irrespective of the mechanism
involved, these data directly demonstrate that FMRP controls
polypeptide elongation and that Fragile X may be a disease, at
least in part, of accelerated ribosome translocation.
Because the ribosome has intrinsic helicase-like activity and is
capable of removing protein/RNA complexes as it moves along
the mRNA (Takyar et al., 2005), FMRP acting as a simple road-
block to stall ribosomes, while tenable as a model, seems too
simplistic. An intriguing structural study of Drosophila FMRP
showed that it binds directly to the ribosome via an interaction
with ribosomal protein L5 (Chen et al., 2014). The two KH (hnRNP
K homology) domains of FMRP interact with the ribosome, while
the single RGG (arginine-glycine-glycine) box could associate
directly with RNA, suggesting that FMRPmay act as a bridge be-
tween the two to impede ribosome movement (Figure 2). How-
ever, such a configuration does not predict whether the speci-
ficity of FMRP binding is imparted by its association with the
mRNA or the ribosome.
One extant question arising from the above discussion is
whether FMRP-mediated translational repression is permanent
or reversible. At least one form of synaptic plasticity, LTD, in-
duces FMRP phosphorylation and ubiquitin-mediated destruc-
tion (Nalavadi et al., 2012; Huang et al., 2015), which one sur-
mises would remove the block to ribosome translocation and
allow polypeptide elongation to proceed.
Ribosome Stalling in Neurodegeneration
The brain contains the most complex mixture of mRNAs of any
adult tissue, and therefore, it is not surprising that translationalCell 163control is becoming a hallmark of neural
development and function. One stunning
observation on translational control at
the level of ribosome translocation
came from a mutagenesis screen for
neurological disorders in mice where
one line in particular displayed profound
brain degeneration, ataxia, and death
by about 2 months of age (Ishimura
et al., 2014). Mapping the mutation bycrosses to congenic mouse strains combined with SNP analysis
showed that the mutagen (N-ethyl-N-nitrosourea) produced a
point mutation in a splice site of the Gtpbp2 gene, which en-
codes a protein with homology to GTPases involved in transla-
tion, particularly the ribosome recycling factors HBS1 and
eRF3. These two proteins interact with the ribosome release
factors Dom34 (yeast nomenclature) and eRF1, and GTPBP2
does indeed co-immunoprecipitate with Pelota, the mammalian
homolog of Dom34. However, neurodegeneration was manifest
only in the commonly used C57BL/6J background, suggesting
that a second modifier gene specific to this strain was neces-
sary to produce the phenotype. The modifier gene was found
to encode an arginine tRNA isodecoder (isodecoder tRNAs
share the same anticodon but have changes elsewhere in the
molecule). This arginine tRNAUCU, which contains a single C
to U mutation in the T-stem loop that is likely to result in
RNA misfolding, is CNS specific; in contrast, GTPBP2 is widely
expressed. Ishimura et al. (2014) hypothesized that the
mutant tRNAArgUCU would cause the ribosome to stall at
AGA codons. Indeed, ribosome profiling (Ingolia et al., 2009) re-
vealed a particularly high number of reads at AGA codons in
cerebellar material containing the mutant tRNA, indicating
strong ribosome stalling at these sites. Such strong stalling
was not evident in cerebellar tissue from animals with wild-
type tRNAArgUCU (Ishimura et al., 2014). Thus, ribosome stalling
at AGA codons caused by the mutant tRNA may allow mutant
GTPBP2 to recruit Pelota and promote premature polypeptide
release, resulting in neurodegeneration (Figure 2) (Ishimura
et al., 2014; Darnell 2014). tRNA mis-charging (Lee et al.,
2006) or mis-folding appears to have particularly profound con-
sequences for CNS function, suggesting that disruption of tRNA
activity could contribute to other CNS pathologies as well., October 8, 2015 ª2015 Elsevier Inc. 295
Polysome Pausing by Misfolded Proteins
Cellular stress has long been known to cause reduced transla-
tion and promote the formation of stress granules and process-
ing bodies (p bodies) where mRNAs have been hypothesized to
undergo silencing and decay, respectively (Anderson andKeder-
sha 2009; Decker and Parker 2012). Proteotoxicity can be one
source of cellular stress and can be simulated by feeding cells
with amino acid analogs that result in misfolded proteins. Liu
et al. (2013) found that culturing cells in L-azetdine-2-carboxylic
acid (AZC), a proline analog, caused rapid turnover of newly syn-
thesized protein, and when AZC treatment was combined with
the proteasome inhibitor MG132, protein synthesis substantially
decreased. This treatment did not induce rapid stress granule
formation or eIF2a phosphorylation, which are common stress-
induced events (Proud, 2005), nor did it alter other parameters
normally associated with a block at initiation. Instead, AZC and
MG132 caused polypeptide elongation to slow. Ribosome
profiling showed that the stress promoted ribosome stalling
within 50 codons of the initiation AUG, enough to encode a
polypeptide partially buried in the exit tunnel of the ribosome
and partially exposed to the cellular milieu. Liu et al. (2013) hy-
pothesized that, because the chaperone HSC70 binds and helps
fold nascent peptides as they emerge from the ribosome, it
would naturally facilitate ribosome transit. During proteotoxic
stress, however, the chaperone may be titrated by misfolded
protein and thus cause ribosome stalling and reduced translation
(Figure 2).
Heat shock, perhaps of the most common form of stress, has
been known for decades to inhibit protein synthesis at least
partly at the level of elongation (Ballinger and Pardue 1983). Us-
ing ribosome profiling, Shalgi et al. (2013) found that heat stress
induces widespread stalling at about codon 65. Similar to the
data presented by Liu et al. (2013), this study found that
HSP70 was responsible for the ribosomal stall. Although Shalgi
et al. (2013) did not determine how the chaperone induces stall-
ing during heat stress, they suggest that it may involve HSP70
association with the emergent nascent peptide, that it somehow
clogs the peptide exit tunnel, or that it mitigates elongation factor
activity.
An additional mode by which heat shock proteins modulate
elongation comes out of structural analysis of yeast ribosomes
(Zhang et al., 2014). A ribosome-associated complex (RAC),
which is composed of HSP40 and HSP70, binds both ribosomal
subunits through a single long alpha helix. As a consequence, a
necessary rotation between the subunits during translation is
limited and thus ribosome translocation is reduced. Zhang
et al. (2014) propose that RAC somehow responds to the folding
needs of the nascent peptide as it emerges from the exit tunnel
and binds the ribosome to reduce translocation such that the
peptide can assume a productive tertiary structure.
Caloric restriction or nutrient deprivation also induces cell
stress. Although a number of proteins can sense that nutrients
are in short supply, the major one is mTORC1 (mTOR complex
1). When amino acid levels are low, this kinase is inactivated,
which leads to a number of downstream dephosphorylation
events, including that of 4EBP1. The non-phosphorylated form
of this protein disrupts the ability of eIF4E to bind eIF4G and re-
cruit factors necessary to initiate translation. A second nutrient296 Cell 163, October 8, 2015 ª2015 Elsevier Inc.sensor is AMP kinase (AMPK). In response to amino acid starva-
tion, it downregulates protein synthesis and other high ATP-
demanding processes in an effort to conserve energy. One
way AMPK accomplishes this task is by activating eEF2 kinase
(eEF2K), which reduces elongation by phosphorylating eEF2
(Leprivier et al., 2013). Through this kind of energy conservation,
AMPK-mediated eEF2 phosphorylation promotes cell survival in
the face of nutrient restriction.
Perhaps the most unusual but well-defined example of stress-
regulated elongation is yeast Hac1 mRNA, which encodes a
transcription factor involved in the unfolded protein response
(UPR). As the 50end of Hac1 mRNA emerges, it associates with
ribosomes and begins to be translated. When the 30 UTR enters
the cytoplasm, an intron contained within it base pairs with the
50UTR, thereby forming a closed loop that stalls the ribosomes.
In response to ER stress, the 30 UTR intron is removed by the
nuclease Ire1p and the RNA ends are unconventionally spliced
by tRNA ligase, which consequently allows the ribosomes to
continue to catalyze polypeptide elongation (Chapman andWal-
ter 1997; Ru¨egsegger et al., 2001).
Regulated Elongation during Oncogenic Transformation
The AMPK-eEF2 kinase pathway mediates tumorigenesis, as
well as caloric-restriction-induced stress. When tumor cells
with low levels of eEF2K are starved, polypeptide elongation re-
mains robust and energy is consumed at a high rate, thereby
causing the cells to undergo apoptosis. However, some tumor
cells can adapt to starvation conditions by upregulating the
AMPK-eEF2 pathway, which inhibits polypeptide elongation,
conserves energy, and promotes cell survival.
mTOR is a master regulator of cell physiology and can induce
many types of cancer through phosphorylation of 4EBP1 and
other substrates. As noted previously, 4EBP1 inhibits initiation
by competitively binding eIF4E to the exclusion of eIF4G.
When 4EBP1 is phosphorylated, it dissociates from eIF4E, which
allows eIF4E, eIF4G, and eIF4A to form the eIF4F initiation com-
plex. As a consequence of these events, mRNAswith particularly
long and complex 50 UTRs are preferentially translated because
eIF4A is an RNA helicase that unwinds RNA secondary structure.
ManymRNAs encoding oncogenes or growth-promoting factors
have complex 50 UTRs and are upregulated by mTOR and pro-
mote cellular transformation (Pelletier et al., 2015). mTOR can
also modulate polypeptide elongation to facilitate cell prolifera-
tion and cancer etiology. In intestinal cancer caused by muta-
tions in adenomatous polyposis coli (APC), a tumor suppressor,
mTORC1 can modulate translation via phosphorylation of
4EBP1 or S6 kinase (S6K), the latter of which is an upstream in-
activator of eEF2K. Thus, at least for this cancer type, tumor
growth is regulated by an axis of mTORC1-S6K-eEF2K-eEF2,
which culminates in decreased elongation rates that are sensi-
tive to the levels of S6K, but not 4EBP1 (Faller et al., 2015).
Regulation by tRNAs
In the previous examples, we have seen that mRNA-specific
regulation might be achieved by turning translational elonga-
tion on or off. In addition to these specialized cases, some evi-
dence hints that the control of translation elongation might
broadly occur and be critical for gene regulation. Unlike the
Figure 3. Illustration of the Concept of
Optimality
(A) Illustration of codon optimality showing two
hypothetical mRNAs. The green circles represent
optimal codons, whereas the red circles represent
non-optimal codons. Designation of codons as
optimal or non-optimal is a function of the con-
centration of tRNA in the cell. The green tRNA
concentrations are high, whereas the red tRNA
concentrations are low; this difference impacts the
speed of elongation.
(B) Differentiated and proliferative cells have var-
ied concentrations of tRNAs that are tailored to the
decoding requirements of the expressed mRNAs.
In this example, differentiated cells have an
abundance of certain types of tRNAs (depicted in
blue) because the mRNAs they express require
similarly high levels of the corresponding codons.
Conversely, proliferating cells contain different
sets of tRNAs (in orange) to match the codons in
mRNAs enriched in these cells (see Gingold et al.,
2014).aforementioned binary switches, ribosome translocation rates
may subtly influence the expression of all messages. If transloca-
tion rates are mRNA specific, then elongation would play a
pivotal role in the synthesis, folding, and perhaps function of all
proteins. The hypothesis that each mRNA has a distinct elonga-
tion rate is based on the notion of supply and demand: supply
of functional tRNAs and demand by expressed codons. In this
light, tRNAs are implicated as critical regulators of the expressed
transcriptome.
In 1968, Francis Crick referred to the degeneracy of the ge-
netic code as a ‘‘frozen accident’’ based on the required 64 com-
binations needed to code for 20 amino acids (Crick, 1968). Since
then, a prevailing zeitgeist has been that synonymous codon
substitutions are silent, having no bearing on gene function. Anti-
thetically, a growing body of literature suggests that synony-
mous codons are differentially recognized by the translational
apparatus. This concept has been referred to as codon opti-
mality (Reis et al., 2004; Novoa and Ribas de Pouplana, 2012;
Pechmann and Frydman, 2013; Krisko et al., 2014). Codon opti-
mality should not be confused with codon usage or bias. Codon
usage/bias is the overrepresentation of certain codons within the
genome and is the result of numerous selective pressures,
including translational elongation rate, translational accuracy,
splicing, and 50 UTR structure (Akashi, 1994; Parmley et al.,
2006; Drummond and Wilke, 2008; Gu et al., 2010). The term
codon optimality has been introduced in an attempt to specif-
ically define the differential recognition of codons by the transla-
tional apparatus and is a property that is distinct from the usageCell 163of codons within the genome. For
instance, commonly occurring codons
can be classified as optimal or non-
optimal, whereas uncommon codons
can also be optimal or non-optimal with
respect to their influence on translational
elongation rate (Presnyak et al., 2015).
Conceptually, codon optimality reflects
the balance between the supply of
charged tRNA molecules and their de-
mand imposed by the concentration of codons engaged in trans-
lation (Figure 3). Thus, the ribosome decodes some codons
quickly because their cognate tRNAs are abundant, whereas
other codons are read more slowly because their tRNA concen-
trations are more limiting (Tuller et al., 2010; Novoa and Ribas de
Pouplana, 2012). In addition, codon optimality is based some-
what on the accuracy of tRNA anticodon/codon interactions,
which can influence decoding rate (Akashi, 1994; Drummond
andWilke, 2008). The theory that each codon is read by the ribo-
some at subtly distinct rates would predict that the kinetics of
protein synthesis are determined by the primary sequence of
every gene (Presnyak et al., 2015). Thus, the overall elongation
rate is the sum of each codon’s infinitesimally small effect on
ribosome translocation. Recent support for this hypothesis has
come from several labs demonstrating that codon optimality is
a powerful determinant of both mRNA translation elongation
andmRNA stability, which are tightly coupled events (Pechmann
and Frydman, 2013; Presnyak et al., 2015).
If codon content dictates translational elongation rate, then
perhaps it can be regulated by changing the functional concen-
tration of tRNAs. If tRNA pools change in response to stress,
environmental conditions, or other biological cues, then so
would the rate at which a codon is read and thus ultimately ribo-
some translocation rates. Recent studies demonstrate that tRNA
levels and modifications indeed fluctuate in response to biolog-
ical cues. First, Gingold et al. (2014) demonstrated that tRNA
pools fluctuate in over 470 tumor samples when compared to
quiescent cells. Specifically, a subset of tRNAs is induced in, October 8, 2015 ª2015 Elsevier Inc. 297
proliferating cells and repressed in quiescent cells. Moreover, a
distinct subset of tRNAs is repressed in proliferating cells that are
active in quiescent cells. Importantly, the tRNAs that are induced
during proliferation often have anticodons corresponding to co-
dons enriched in cell-autonomous genes. In contrast, tRNAs
induced in differentiated cells carry anticodons for codons en-
riched in mRNAs for cell adhesion, cell-junction assembly, toll-
like receptor signaling, and extracellular matrix genes. In a study
in whichmouse embryonic development was examined, Schmitt
et al. (2014) demonstrated that tRNA expression patterns were
controlled to generate an anticodon pool that corresponds to
the codon demand by mRNAs (Schmitt et al., 2014). Thus, the
patterns of tRNA expression match codon usage within the ex-
pressed transcriptome (Figure 3).
Stress can also alter the level of functional tRNAs within a cell.
Specifically, reprogramming of tRNA modifications occurs in
cells exposed to different conditions. Chan et al. (2012) demon-
strated that exposure of cells to hydrogen peroxide results in an
increase in the amount of tRNALeu(CAA) containing 5-methylcyto-
sine (m5C) at the wobble position. This increase in m5C causes
selective translation of mRNAs enriched in the TTG codon. A
nutrient-driven tRNA modification has also been observed in
Drosophila. Here, the bioavailability of queuine (a modified
base) affects the levels of queuosine-modified tRNAs (Zaborske
et al., 2014). Queuine is scavenged by eukaryotes from the
tRNAs of bacteria and absorbed in the gut where, at least in flies,
it alters translation profiles. Together, these data suggest that
tRNA pools can and do fluctuate in response to biological
cues. If these concepts occurmore broadly, then it places tRNAs
as important and under-appreciated regulators of mRNA post-
transcriptional regulation.
Why Regulate at Elongation?
The regulation of translational elongation might afford several
advantages to an mRNA and the cell. First, loading an mRNA
onto polyribosomes and then stalling the polysomes in
response to the presence or absence of a stimulus would allow
instantaneous production of new polypeptides once the stim-
ulus was changed. This rapid response might be especially
important in situations where, as in neurons, immediate protein
synthesis is needed in response to synaptic stimulation. Lod-
ging mRNA on translationally quiescent polyribosomes might
also serve a protective function, limiting access by nucleases.
In the cell, RNAs tend to be degraded when not associated
with protein factors; therefore, unless there are active events re-
organizing the mRNA out of translation and into a translation-
repressed ribonucleoprotein complex (e.g., stress granules or
maternal mRNA storage granules), polyribosomes might serve
a protective role.
Basal regulation of elongation rate by tRNAs might in fact be a
primary driver of protein levels within the cell. It was recently
observed that tightly coordinated optimal codon content occurs
in genes encoding proteins with common physiological function
(Presnyak et al., 2015). This finding suggests that there is evolu-
tionary pressure toward certain synonymous codon usage to co-
ordinate gene expression at the level of protein synthesis and
mRNA decay. The coordination of protein complexes through
coordinate codon-dependent elongation rates would provide298 Cell 163, October 8, 2015 ª2015 Elsevier Inc.an elegant mechanism to ensure a consistent stoichiometric
relationship between all members of a given complex. Because
this coordination is based on codon choice, changing tRNA
levels and/or modifications would provide a simple yet sophisti-
cated means to uniformly regulate an entire physiological pro-
cess by changing ribosome elongation rates.
The Road Ahead
The advent of ribosome profiling (Ingolia et al., 2009), which dis-
plays stalled ribosomes on an mRNA-specific and codon-spe-
cific basis, has firmly placed elongation on the map of important
gene regulatory mechanisms. Although, in most cases, the
salient molecular details for stalling are just beginning to come
into focus, perhaps some general principles may be involved.
One is exemplified by FMRP in which a protein acts on a group
of mRNAs to stall ribosome translocation. Certainly, intrinsic
mRNA sequence gives specificity to the stalling, but is there
also something intrinsic to the ribosome that allows it to be
stalled? For example, we know the ribosome has trouble with
lysine AAA codons (Koutmou et al., 2015) and that polyproline
in the exit tunnel can also slow elongation (Gutierrez et al.,
2013). Thus, certain ribosome characteristics could be exploited
by an mRNA to slow elongation, and consolidation of this event
could occur through a second factor such as FMRP. Extrapola-
tion of the data from several studies on FMRP suggests that this
could be the case and that both message and ribosome
contribute to the stalling.
A second general principle centers on tRNA. The astonishing
study of Ishimura et al. (2014) shows that the brain contains a
tRNA that is absent from other tissues. When this tRNA has a
single base change, ribosomes stall at its cognate mRNA
codon. This stall results in CNS-specific pathology in instances
where GTPBP2 is also mutated. Is tRNA specificity wide-
spread, and if so, how does it influence health and disease?
A corollary of tRNA tissue specificity is ‘‘optimality’’—the
matchup between codon prevalence and relative of abundance
of the tRNA bearing the anticodon. If this ratio becomes
skewed during development or times of stress, it is easy to
see how it could alter ribosome translocation and result in a
biological transition.
Therapeutics aimed at the translational landscape have, for
the most part, concentrated on initiation (e.g., Pelletier et al.,
2015). Importantly, however, just this year, a novel multiple-
stage antimalarial agent was discovered whose target is Elonga-
tion Factor 2 (Baragan˜a et al., 2015). Thus, we wonder whether
the elongation phase of protein synthesis is an equally promising
target for therapeutic intervention to ameliorate disease.
ACKNOWLEDGMENTS
We thank Drs. Lori Lorenz, Botao Liu, and Sophie Martin for comments on the
manuscript. Work from the authors’ laboratories was supported by grants from
the National Institutes of Health (R01 GM46779, R01 NS079415, and U54
082013 to J.D.R. and R01 GM080465 to J.C.).
REFERENCES
Akashi, H. (1994). Synonymous codon usage in Drosophilamelanogaster: nat-
ural selection and translational accuracy. Genetics 136, 927–935.
Anderson, P., and Kedersha, N. (2009). RNA granules: post-transcriptional
and epigenetic modulators of gene expression. Nat. Rev. Mol. Cell Biol. 10,
430–436.
Andrews, S., Snowflack, D.R., Clark, I.E., and Gavis, E.R. (2011). Multiple
mechanisms collaborate to repress nanos translation in the Drosophila ovary
and embryo. RNA 17, 967–977.
Ballinger, D.G., and Pardue, M.L. (1983). The control of protein synthesis dur-
ing heat shock in Drosophila cells involves altered polypeptide elongation
rates. Cell 33, 103–113.
Baragan˜a, B., Hallyburton, I., Lee, M.C.S., Norcross, N.R., Grimaldi, R., Otto,
T.D., Proto, W.R., Blagborough, A.M., Meister, S., Wirjanata, G., et al. (2015). A
novel multiple-stage antimalarial agent that inhibits protein synthesis. Nature
522, 315–320.
Bazzini, A.A., Lee, M.T., and Giraldez, A.J. (2012). Ribosome profiling shows
that miR-430 reduces translation before causing mRNA decay in zebrafish.
Science 336, 233–237.
Bhattacharya, A., Kaphzan, H., Alvarez-Dieppa, A.C., Murphy, J.P., Pierre, P.,
and Klann, E. (2012). Genetic removal of p70 S6 kinase 1 corrects molecular,
synaptic, and behavioral phenotypes in fragile X syndrome mice. Neuron 76,
325–337.
Braat, A.K., Yan, N., Arn, E., Harrison, D., and Macdonald, P.M. (2004). Local-
ization-dependent oskar protein accumulation; control after the initiation of
translation. Dev. Cell 7, 125–131.
Brandis, J.W., and Raff, R.A. (1978). Translation of oogenetic mRNA in sea
urchin eggs and early embryos. Demonstration of a change in translational
efficiency following fertilization. Dev. Biol. 67, 99–113.
Buxbaum, A.R., Wu, B., and Singer, R.H. (2014). Single b-actin mRNA detec-
tion in neurons reveals a mechanism for regulating its translatability. Science
343, 419–422.
Chan, C.T.Y., Pang, Y.L.J., Deng, W., Babu, I.R., Dyavaiah, M., Begley, T.J.,
and Dedon, P.C. (2012). Reprogramming of tRNA modifications controls
the oxidative stress response by codon-biased translation of proteins. Nat.
Commun. 3, 937.
Chapman, R.E., and Walter, P. (1997). Translational attenuation mediated by
an mRNA intron. Curr. Biol. 7, 850–859.
Chen, E., Sharma,M.R., Shi, X., Agrawal, R.K., and Joseph, S. (2014). Fragile X
mental retardation protein regulates translation by binding directly to the ribo-
some. Mol. Cell 54, 407–417.
Clark, I.E., Wyckoff, D., and Gavis, E.R. (2000). Synthesis of the posterior
determinant Nanos is spatially restricted by a novel cotranslational regulatory
mechanism. Curr. Biol. 10, 1311–1314.
Corbin, F., Bouillon, M., Fortin, A., Morin, S., Rousseau, F., and Khandjian,
E.W. (1997). The fragile Xmental retardation protein is associated with poly(A)+
mRNA in actively translating polyribosomes. Hum. Mol. Genet. 6, 1465–1472.
Crick, F.H. (1968). The origin of the genetic code. J. Mol. Biol. 38, 367–379.
Darnell, J.C. (2014). Molecular biology. Ribosome rescue and neurodegener-
ation. Science 345, 378–379.
Darnell, J.C., Van Driesche, S.J., Zhang, C., Hung, K.Y., Mele, A., Fraser, C.E.,
Stone, E.F., Chen, C., Fak, J.J., Chi, S.W., et al. (2011). FMRP stalls ribosomal
translocation on mRNAs linked to synaptic function and autism. Cell 146,
247–261.
Decker, C.J., and Parker, R. (2012). P-bodies and stress granules: possible
roles in the control of translation and mRNA degradation. Cold Spring Harb.
Perspect. Biol. 4, a012286.
Do¨len, G., Osterweil, E., Rao, B.S., Smith, G.B., Auerbach, B.D., Chattarji, S.,
and Bear, M.F. (2007). Correction of fragile X syndrome in mice. Neuron 56,
955–962.
Drummond, D.A., and Wilke, C.O. (2008). Mistranslation-induced protein
misfolding as a dominant constraint on coding-sequence evolution. Cell 134,
341–352.
Faller, W.J., Jackson, T.J., Knight, J.R., Ridgway, R.A., Jamieson, T., Karim,
S.A., Jones, C., Radulescu, S., Huels, D.J., Myant, K.B., et al. (2015).mTORC1-mediated translational elongation limits intestinal tumour initiation
and growth. Nature 517, 497–500.
Feng, Y., Absher, D., Eberhart, D.E., Brown, V., Malter, H.E., and Warren, S.T.
(1997). FMRP associates with polyribosomes as an mRNP, and the I304N
mutation of severe fragile X syndrome abolishes this association. Mol. Cell
1, 109–118.
Gingold, H., Tehler, D., Christoffersen, N.R., Nielsen, M.M., Asmar, F., Koois-
tra, S.M., Christophersen, N.S., Christensen, L.L., Borre, M., Sørensen, K.D.,
et al. (2014). A dual program for translation regulation in cellular proliferation
and differentiation. Cell 158, 1281–1292.
Graber, T.E., He´bert-Seropian, S., Khoutorsky, A., David, A., Yewdell, J.W.,
Lacaille, J.C., and Sossin, W.S. (2013). Reactivation of stalled polyribosomes
in synaptic plasticity. Proc. Natl. Acad. Sci. USA 110, 16205–16210.
Gross, C., Raj, N., Molinaro, G., Allen, A.G., Whyte, A.J., Gibson, J.R., Huber,
K.M., Gourley, S.L., andBassell, G.J. (2015). Selective role of the catalytic PI3K
subunit p110b in impaired higher order cognition in fragile X syndrome. Cell
Rep. 11, 681–688.
Gu, W., Zhou, T., and Wilke, C.O. (2010). A universal trend of reduced mRNA
stability near the translation-initiation site in prokaryotes and eukaryotes. PLoS
Comput. Biol. 6, e1000664.
Gutierrez, E., Shin, B.-S., Woolstenhulme, C.J., Kim, J.-R., Saini, P., Buskirk,
A.R., and Dever, T.E. (2013). eIF5A promotes translation of polyproline motifs.
Mol. Cell 51, 35–45.
Halic, M., Becker, T., Pool, M.R., Spahn, C.M.T., Grassucci, R.A., Frank, J.,
and Beckmann, R. (2004). Structure of the signal recognition particle interact-
ing with the elongation-arrested ribosome. Nature 427, 808–814.
Hinnebusch, A.G. (2014). The scanning mechanism of eukaryotic translation
initiation. Annu. Rev. Biochem. 83, 779–812.
Huang, J., Ikeuchi, Y., Malumbres, M., and Bonni, A. (2015). A Cdh1-APC/
FMRP ubiquitin signaling link drives mGluR-dependent synaptic plasticity in
the mammalian brain. Neuron 86, 726–739.
Ingolia, N.T., Ghaemmaghami, S., Newman, J.R., and Weissman, J.S. (2009).
Genome-wide analysis in vivo of translation with nucleotide resolution using
ribosome profiling. Science 324, 218–223.
Ishimura, R., Nagy, G., Dotu, I., Zhou, H., Yang, X.L., Schimmel, P., Senju, S.,
Nishimura, Y., Chuang, J.H., and Ackerman, S.L. (2014). RNA function. Ribo-
some stalling induced by mutation of a CNS-specific tRNA causes neurode-
generation. Science 345, 455–459.
Kanai, Y., Dohmae, N., and Hirokawa, N. (2004). Kinesin transports RNA: isola-
tion and characterization of an RNA-transporting granule. Neuron 43, 513–525.
Kang, H., and Schuman, E.M. (1996). A requirement for local protein synthesis
in neurotrophin-induced hippocampal synaptic plasticity. Science 273, 1402–
1406.
Koutmou, K.S., Schuller, A.P., Brunelle, J.L., Radhakrishnan, A., Djuranovic,
S., and Green, R. (2015). Ribosomes slide on lysine-encoding homopolymeric
A stretches. eLife 4. http://dx.doi.org/10.7554/eLife.05534.
Krichevsky, A.M., and Kosik, K.S. (2001). Neuronal RNA granules: a link be-
tween RNA localization and stimulation-dependent translation. Neuron 32,
683–696.
Krisko, A., Copic, T., Gabaldo´n, T., Lehner, B., and Supek, F. (2014). Inferring
gene function from evolutionary change in signatures of translation efficiency.
Genome Biol. 15, R44.
Lee, R.C., Feinbaum, R.L., and Ambros, V. (1993). The C. elegans hetero-
chronic gene lin-4 encodes small RNAs with antisense complementarity to
lin-14. Cell 75, 843–854.
Lee, J.W., Beebe, K., Nangle, L.A., Jang, J., Longo-Guess, C.M., Cook, S.A.,
Davisson, M.T., Sundberg, J.P., Schimmel, P., and Ackerman, S.L. (2006). Ed-
iting-defective tRNA synthetase causes protein misfolding and neurodegener-
ation. Nature 443, 50–55.
Leprivier, G., Remke, M., Rotblat, B., Dubuc, A., Mateo, A.R., Kool, M., Agni-
hotri, S., El-Naggar, A., Yu, B., Somasekharan, S.P., et al. (2013). The eEF2
kinase confers resistance to nutrient deprivation by blocking translation elon-
gation. Cell 153, 1064–1079.Cell 163, October 8, 2015 ª2015 Elsevier Inc. 299
Liu, B., Han, Y., and Qian, S.B. (2013). Cotranslational response to proteotoxic
stress by elongation pausing of ribosomes. Mol. Cell 49, 453–463.
Mamane, Y., Petroulakis, E., Rong, L., Yoshida, K., Ler, L.W., and Sonenberg,
N. (2004). eIF4E–from translation to transformation. Oncogene 23, 3172–3179.
Maroney, P.A., Yu, Y., Fisher, J., and Nilsen, T.W. (2006). Evidence that micro-
RNAs are associated with translating messenger RNAs in human cells. Nat.
Struct. Mol. Biol. 13, 1102–1107.
Martin, K.C., Casadio, A., Zhu, H., Yaping, E., Rose, J.C., Chen, M., Bailey,
C.H., and Kandel, E.R. (1997). Synapse-specific, long-term facilitation of aply-
sia sensory tomotor synapses: a function for local protein synthesis inmemory
storage. Cell 91, 927–938.
Nalavadi, V.C., Muddashetty, R.S., Gross, C., and Bassell, G.J. (2012).
Dephosphorylation-induced ubiquitination and degradation of FMRP in den-
drites: a role in immediate early mGluR-stimulated translation. J. Neurosci.
32, 2582–2587.
Nottrott, S., Simard, M.J., and Richter, J.D. (2006). Human let-7a miRNA
blocks protein production on actively translating polyribosomes. Nat. Struct.
Mol. Biol. 13, 1108–1114.
Novoa, E.M., and Ribas de Pouplana, L. (2012). Speeding with control: codon
usage, tRNAs, and ribosomes. Trends Genet. 28, 574–581.
Olsen, P.H., and Ambros, V. (1999). The lin-4 regulatory RNA controls develop-
mental timing in Caenorhabditis elegans by blocking LIN-14 protein synthesis
after the initiation of translation. Dev. Biol. 216, 671–680.
Parmley, J.L., Chamary, J.V., and Hurst, L.D. (2006). Evidence for purifying se-
lection against synonymous mutations in mammalian exonic splicing en-
hancers. Mol. Biol. Evol. 23, 301–309.
Pechmann, S., and Frydman, J. (2013). Evolutionary conservation of codon
optimality reveals hidden signatures of cotranslational folding. Nat. Struct.
Mol. Biol. 20, 237–243.
Pelletier, J., Graff, J., Ruggero, D., and Sonenberg, N. (2015). Targeting the
eIF4F translation initiation complex: a critical nexus for cancer development.
Cancer Res. 75, 250–263.
Petersen, C.P., Bordeleau, M.E., Pelletier, J., and Sharp, P.A. (2006). Short
RNAs repress translation after initiation in mammalian cells. Mol. Cell 21,
533–542.
Presnyak, V., Alhusaini, N., Chen, Y.H., Martin, S., Morris, N., Kline, N., Olson,
S., Weinberg, D., Baker, K.E., Graveley, B.R., and Coller, J. (2015). Codon opti-
mality is a major determinant of mRNA stability. Cell 160, 1111–1124.
Proud, C.G. (2005). eIF2 and the control of cell physiology. Semin. Cell Dev.
Biol. 16, 3–12.
Reis, M.D., Savva, R., and Wernisch, L. (2004). Solving the riddle of codon us-
age preferences: a test for translational selection. Nucleic Acids Res. 32,
5036–5044.
Richter, J.D., and Sonenberg, N. (2005). Regulation of cap-dependent transla-
tion by eIF4E inhibitory proteins. Nature 433, 477–480.300 Cell 163, October 8, 2015 ª2015 Elsevier Inc.Richter, J.D., Wasserman, W.J., and Smith, L.D. (1982). The mechanism for
increased protein synthesis during Xenopus oocyte maturation. Dev. Biol.
89, 159–167.
Ru¨egsegger, U., Leber, J.H., and Walter, P. (2001). Block of HAC1 mRNA
translation by long-range base pairing is released by cytoplasmic splicing
upon induction of the unfolded protein response. Cell 107, 103–114.
Scheetz, A.J., Nairn, A.C., and Constantine-Paton, M. (2000). NMDA receptor-
mediated control of protein synthesis at developing synapses. Nat. Neurosci.
3, 211–216.
Schmitt, B.M., Rudolph, K.L.M., Karagianni, P., Fonseca, N.A., White, R.J., Ta-
lianidis, I., Odom, D.T., Marioni, J.C., and Kutter, C. (2014). High-resolution
mapping of transcriptional dynamics across tissue development reveals a sta-
ble mRNA-tRNA interface. Genome Res. 24, 1797–1807.
Shalgi, R., Hurt, J.A., Krykbaeva, I., Taipale, M., Lindquist, S., and Burge, C.B.
(2013). Widespread regulation of translation by elongation pausing in heat
shock. Mol. Cell 49, 439–452.
Siegel, V., andWalter, P. (1988). Each of the activities of signal recognition par-
ticle (SRP) is contained within a distinct domain: analysis of biochemical mu-
tants of SRP. Cell 52, 39–49.
Stefani, G., Fraser, C.E., Darnell, J.C., and Darnell, R.B. (2004). Fragile X
mental retardation protein is associated with translating polyribosomes in
neuronal cells. J. Neurosci. 24, 7272–7276.
Sutton, M.A., Taylor, A.M., Ito, H.T., Pham, A., and Schuman, E.M. (2007).
Postsynaptic decoding of neural activity: eEF2 as a biochemical sensor
coupling miniature synaptic transmission to local protein synthesis. Neuron
55, 648–661.
Takyar, S., Hickerson, R.P., and Noller, H.F. (2005). mRNA helicase activity of
the ribosome. Cell 120, 49–58.
Tuller, T., Carmi, A., Vestsigian, K., Navon, S., Dorfan, Y., Zaborske, J., Pan, T.,
Dahan, O., Furman, I., and Pilpel, Y. (2010). An evolutionarily conservedmech-
anism for controlling the efficiency of protein translation. Cell 141, 344–354.
Udagawa, T., Farny, N.G., Jakovcevski, M., Kaphzan, H., Alarcon, J.M., Anil-
kumar, S., Ivshina, M., Hurt, J.A., Nagaoka, K., Nalavadi, V.C., et al. (2013). Ge-
netic and acute CPEB1 depletion ameliorate fragile X pathophysiology. Nat.
Med. 19, 1473–1477.
Wightman, B., Ha, I., and Ruvkun, G. (1993). Posttranscriptional regulation of
the heterochronic gene lin-14 by lin-4 mediates temporal pattern formation in
C. elegans. Cell 75, 855–862.
Zaborske, J.M., DuMont, V.L.B., Wallace, E.W.J., Pan, T., Aquadro, C.F., and
Drummond, D.A. (2014). A nutrient-driven tRNA modification alters transla-
tional fidelity and genome-wide protein coding across an animal genus.
PLoS Biol. 12, e1002015.
Zhang, Y., Ma, C., Yuan, Y., Zhu, J., Li, N., Chen, C., Wu, S., Yu, L., Lei, J., and
Gao, N. (2014). Structural basis for interaction of a cotranslational chaperone
with the eukaryotic ribosome. Nat. Struct. Mol. Biol. 21, 1042–1046.
